Calmer Co International Limited
AASX:CCO0.00
AUD
0.00
(0.00%)
ISIN
AU0000275216
Return %
Stock
S&P 500
1Y
-66.67
14.20
3Y
-60.09
81.12
5Y
-98.32
68.34
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.Company Description
- CEO
- Zane Yoshida
- Full Time Employees
- 2
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- 24 Cansdale Street West End QLD Australia 4104
- IPO Date
- Dec 20, 2018
- Website
- thecalmerco.com
- Similar Companies
- Business
- The Calmer Co International Limited (ASX:CCO) operates as a health and wellness company focused on producing and selling kava-based nutraceuticals and functional beverages to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance; its core products include powdered drinking kava, teas, capsules, cold-pressed shots, liquid concentrates, and tinctures offered under the FijiKava, Taki Mai, and Danodan Hempworks brand names, as well as hemp and CBD oils and topical products. The company maintains a vertically integrated, 100% traceable farm-to-shelf supply chain with an 111-acre nucleus farm in Levuka, Fiji, and sources noble kava exclusively from Fiji through outsourced farms and direct operations, positioning it as the first and only foreign company approved by the Fijian Government to operate in the kava industry. Founded in 2018 and headquartered in West End, Queensland, Australia, it conducts business across Australia, Fiji, the United States, New Zealand, China, and the Pacific Islands through reportable segments including Fiji Kava Australia Trading Pty Ltd, South Pacific Elixirs Pty Limited, Fiji Kava Inc (USA), and Danodan Hempworks LLC (USA), with primary revenue from Australia and additional contributions from Fiji and other regions. Recent developments include a renounceable rights issue in May 2025 raising A$1.0 million through over 333 million new shares and 166 million options to fund capital expenditure, inventory expansion, brand promotion, and operations; strategic retail expansions such as Taki Mai cold-pressed kava shots into over 800 Coles supermarkets in Australia and distribution partnerships like Walmart in the US and Leilo kava drinks in Fiji; multiple equity placements and issuances in late 2024 and 2025 to directors and management; and a name change from Fiji Kava Limited in April 2023.